Peripheral neuropathy decisions — 2025

The Board granted earlier effective dates of August 10, 2022, for the grants of service connection for right and left lower extremity diabetic peripheral neuropathy and diabetic retinopathy. The claim for an increased rating for diabetes mellitus, type II, with erectile dysfunction was denied.

The Board remands the veteran's claims for increased ratings and other benefits due to incomplete records.

The Board remands the claims for service connection for various disabilities due to a lack of proper notification and scheduling of VA examinations.

The Board denied earlier effective dates for service connection and remanded a compensable rating claim due to missing pulmonary function test results.

The Board denied service connection for headaches, an acquired psychiatric disorder (generalized anxiety with insomnia features), and diabetic peripheral neuropathy of the upper and lower extremities. The effective date for these conditions was set to October 2, 2023.

The Board denied service connection for various disabilities, including prostate disability (BPH), nummular eczema, nephrolithiasis, neuropathy in both upper and lower extremities, and pseudophakia as secondary to diabetes mellitus, type II, due to a lack of evidence supporting a causal relationship between the disabilities and the Veteran's active service, including herbicide agent exposure.

The Board denied service connection for autoimmune arthritis and denied initial ratings in excess of 10 percent, 60 percent, and 20 percent for atrial fibrillation, coronary artery disease, and diabetes mellitus, respectively. The Board also denied an initial compensable rating for a residual scar associated with CAD and denied initial ratings in excess of 10 percent for bilateral lower extremity femoral and sciatic nerve neuropathies.

The Board granted service connection for peripheral neuropathy of the sciatic nerve in both lower extremities and a psychiatric disorder, but denied service connection for Raynaud's disease, muscle pain, degenerative arthritis, peripheral neuropathy of the ulnar and musculocutaneous nerves in both upper extremities, squamous cell carcinoma, and migraines.

The Board denied the veteran's claims for increased ratings for GERD, peripheral neuropathy of the lower right extremity, and peripheral neuropathy of the lower left extremity.

The Board remands the claims for service connection for peripheral neuropathy of the right and left lower extremities due to a need for an examination to determine their etiology.

The Board granted an earlier effective date of April 28, 2021, for the award of service connection for bilateral upper and lower extremity diabetic neuropathies.

The Board granted an effective date of October 29, 2016, for the award of a 70 percent rating for posttraumatic stress disorder with panic disorder but denied earlier effective dates and service connection for other conditions.

The claim for service connection for a left knee condition (to include patellofemoral syndrome and DJD) is remanded for readjudication, as new and relevant evidence has been received sufficient to reopen the claim.

The Board granted an earlier effective date of December 29, 2022, for the award of service connection for PTSD but denied earlier effective dates for rheumatic arthritis and peripheral neuropathy.

The Board granted service connection for obstructive sleep apnea, Barrett's esophagus, and bilateral peripheral neuropathy as secondary to the Veteran's service-connected Non-Hodgkin's lymphoma.

The Board denied earlier effective dates for the assignment of disability ratings of 30 percent and 20 percent for service-connected peripheral neuropathy in the right and left upper extremities, respectively.

The Board granted service connection for bilateral upper and lower extremity neuropathy, secondary to the Veteran's service-connected diabetes mellitus, pursuant to the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022 (PACT Act).

The Board granted service connection for bilateral lower and upper extremity, peripheral neuropathy based on new evidence of relevant exposure to herbicides during active military service.

The Board denied service connection for heart condition and remanded the claims for diabetes mellitus, type II and peripheral neuropathy of the right lower extremity.

The Board granted service connection for hypertension, left foot neuropathy, and right foot neuropathy. The back condition was remanded.